These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2075946)

  • 1. [Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
    Latorre J; Foncuberta J; Rosendo A; Elez J
    Angiologia; 1990; 42(6):218-26. PubMed ID: 2075946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thrombolytic agents].
    Furukawa K
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1166-9. PubMed ID: 6503980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
    de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
    Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of in situ arterial thrombolysis by the combination of urokinase and lysyl plasminogen in acute arterial occlusive diseases of the lower limbs].
    Pernes JM; Brenot P; Raynaud A; Parola JL; Roth JP; Angel CY; Vitoux JF; Fiessinger JN; Roncato M; Gaux JC
    J Radiol; 1985 May; 66(5):385-91. PubMed ID: 4032349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis.
    Badylak SF; Voytik SL; Henkin J; Burke S; Sasahara AA; Simmons A
    Haemostasis; 1991; 21(5):278-85. PubMed ID: 1806456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic treatment of deep venous thrombosis].
    Martínez-Brotons F; Cairols MA
    Sangre (Barc); 1984; 29(4-C):762-6. PubMed ID: 6515512
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
    Naito I
    Rinsho Ketsueki; 1984 Jul; 25(7):1027-35. PubMed ID: 6389929
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--III. Thrombolytic properties of natural and recombinant urokinase in rabbits with experimental jugular vein thrombosis.
    Collen D; Stassen JM; Blaber M; Winkler M; Verstraete M
    Thromb Haemost; 1984 Aug; 52(1):27-30. PubMed ID: 6541817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the thrombolytic efficacy of prourokinase by lys-plasminogen in a dog model of arterial thrombosis.
    Badylak SF; Voytik SL; Henkin J; Burke SE; Sasahara AA; Simmons A
    Thromb Res; 1991 May; 62(3):115-26. PubMed ID: 1716378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
    Kawakami K; Takahashi A; Yoshimoto T
    No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies].
    Vitoux JF; Roncato M; Pernes JM; Fiessinger JN; Aiach M; Gaux JC
    Ann Med Interne (Paris); 1986; 137(2):105-7. PubMed ID: 3717814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y; Ohta T; Kuroiwa T
    Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
    Watahiki Y; Scully MF; Ellis V; Kakkar VV
    Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases.
    Pogliani EM; Bozzani A; Radaelli F; Conte D; Bardella MT; Colombi M; Quatrini M
    Pharmatherapeutica; 1982; 3(4):268-73. PubMed ID: 6755491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy for deep vein thrombosis.
    Persson AV; Persson CA
    Am J Surg; 1985 Oct; 150(4A):50-3. PubMed ID: 4051121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.